Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of aliskiren + valsartan on retinal vascular structure in hypertension
2009-017676-24Phase 3Completed
- Sponsor
- University Hospital Erlangen
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of aliskiren and valsartan in hypertension (HTN), sponsored by University Hospital Erlangen. Primary endpoint: Change in wall-to-lumen ratio of retinal arterioles at 8 weeks. Started Feb 2010; status: completed.
02
Drugs
aliskirenvalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on 2009-017676-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017676-24.